» Authors » G C Trudel

G C Trudel

Explore the profile of G C Trudel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 68
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Trop I, Bourgouin P, Lapierre Y, Duquette P, Wolfson C, Duong H, et al.
AJNR Am J Neuroradiol . 1998 Jul; 19(6):1025-33. PMID: 9672006
Purpose: Although MR findings in multiple sclerosis (MS) are well known, the relationship between MR-detected lesions and clinical activity has not been studied in the spinal cord. The purpose of...
2.
McLaurin J, Trudel G, Shaw I, Antel J, Cashman N
J Neurobiol . 1995 Feb; 26(2):283-93. PMID: 7707048
We have developed a series of immortal human-human hybrid cell lines that express phenotypic characteristics of primary oligodendrocytes, by fusing a 6-thioguanine-resistant mutant of the human rhabdomyosarcoma RD with adult...
3.
Trudel G, Holland P
Biochem Biophys Res Commun . 1992 Apr; 184(1):125-30. PMID: 1373610
The glycoprotein processing inhibitors bromoconduritol and N-methyl-1-deoxynojirimycin inhibit myoblast fusion and differentiation, suggesting the critical involvement of one or more glycoproteins in the control of skeletal myogenesis. In the present...
4.
Trudel G, Holland P
Biochem Cell Biol . 1990 Dec; 68(12):1411-8. PMID: 2150751
Treatment of chick myoblasts with the glucosidase inhibitors bromoconduritol (BCD) or N-methyl-1-deoxynojirimycin (MDJN), but not the mannosidase I inhibitor 1-deoxymannojirimycin (ManDJN), decreased their rate of adhesion to fibronectin and laminin...
5.
Trudel G, Holland P
Biochem Biophys Res Commun . 1989 Sep; 163(3):1338-43. PMID: 2528954
The effect of the glucosidase inhibitors N-methyl-1-deoxynojirimycin (MDJN) and bromoconduritol on the adhesion of chick myoblasts and rat L6 myoblasts to fibronectin and laminin was compared with that of the...
6.
Trudel G, HERSCOVICS A, Holland P
Biochem Cell Biol . 1988 Oct; 66(10):1119-25. PMID: 2975179
It has recently been reported that the glucosidase I inhibitor, N-methyl-1-deoxynojirimycin (MDJN), inhibits myoblast fusion whereas the mannosidase inhibitor, 1-deoxymannojirimycin (ManDJN), has no effect on fusion. We now report that...